Atea Completes Phase 3 Enrollment for Hepatitis C Treatment
Enrollment Completed in C-BEYOND Phase 3 Trial with More Than 880 HCV Treatment-Naïve Patients in US and Canada Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company engaged in the discovery...
